| Target Price | $40.29 |
| Price | $33.29 |
| Potential |
21.03%
register free of charge
|
| Number of Estimates | 14 |
|
14 Analysts have issued a price target Genpact Limited 2027 .
The average Genpact Limited target price is $40.29.
This is
21.03%
register free of charge
$47.25
41.93%
register free of charge
$31.31
5.95%
register free of charge
|
|
| A rating was issued by 20 analysts: 10 Analysts recommend Genpact Limited to buy, 9 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Genpact Limited stock has an average upside potential 2027 of
21.03%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 5.08 | 5.55 |
| 6.56% | 9.18% | |
| EBITDA Margin | 15.47% | 18.79% |
| 1.23% | 21.46% | |
| Net Margin | 10.88% | 12.73% |
| 0.94% | 17.05% |
16 Analysts have issued a sales forecast Genpact Limited 2026 . The average Genpact Limited sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an Genpact Limited EBITDA forecast 2026. The average Genpact Limited EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
16 Genpact Limited Analysts have issued a net profit forecast 2026. The average Genpact Limited net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 3.13 | 4.20 |
| 9.82% | 34.19% | |
| P/E | 7.92 | |
| EV/Sales | 1.13 |
16 Analysts have issued a Genpact Limited forecast for earnings per share. The average Genpact Limited EPS is
This results in the following potential growth metrics and future valuations:
Genpact Limited...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| Susquehanna |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Jul 09 2026 |
| Baird |
Locked
➜
Locked
|
Locked | Jul 07 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Needham:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
Susquehanna:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Jul 09 2026 |
|
Locked
Baird:
Locked
➜
Locked
|
Jul 07 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


